Distil ← Back to home
Medication · maoi

Supplements and Tranylcypromine.

Every documented pair, every citation. Below: 8 documented pairs grouped by mechanism.

Tranylcypromine, sold under the brand name Parnate, is a monoamine oxidase inhibitor (MAOI): it irreversibly inhibits MAO-A and MAO-B, with strict dietary and drug interaction rules.

Tranylcypromine is a monoamine oxidase inhibitor (MAOI). The class irreversibly inhibits MAO-A and MAO-B, raising synaptic monoamine levels. Current UK use is uncommon. It is confined to depression that has resisted other treatments and is managed in specialist psychiatry, because of the strict dietary rules (foods rich in tyramine) and drug interaction rules. The supplement surface is one of the most restrictive in clinical pharmacology. Anything serotonergic stacked on top can drive serotonin syndrome. St John's Wort, 5-HTP, tryptophan, SAMe, and saffron extract are all excluded. Anything sympathomimetic stacks on noradrenergic effect. Caffeine at high doses, yohimbe, bitter orange, ephedra (where available), and even excessive ginseng warrant care. Supplements rich in tyramine and certain protein extracts carry the same hypertensive crisis concern as the dietary tyramine rule. The psychiatric team is the gatekeeper for any new supplement on an MAOI regimen.

Below are the 8 documented pairs we have explicitly assessed against Tranylcypromine in the Distil database: 7 red and 1 amber. The pairs cluster around 2 mechanisms: MAOI pressor (blood-pressure surge) and Additive serotonergic activity. Every call is cited to either a clinical reference (PMID) or the British National Formulary. Anything not on this list is either still to be assessed or beyond our database scope. The checker beneath surfaces assessments by supplement, and the missing-item form at the bottom of the page routes any uncatalogued supplement into our next curation pass.

Documented interactions

MAOI pressor (blood-pressure surge)

L-tyrosine is a building block for noradrenaline and dopamine, and tranylcypromine is an MAOI that stops these from being broken down. Together they could drive blood pressure dangerously high (a hypertensive crisis). Tranylcypromine carries the strongest pressor risk of the MAOIs, so we treat this as a do-not-combine pair without specialist sign-off.

PMID 3097262 · BNF: Tranylcypromine

Reviewer-flagged: awaiting clinical-reviewer sign-off.

Panax ginseng has been linked, in a case with the MAOI phenelzine, to symptoms like insomnia, headache and tremor (a possible mania-like or stimulant reaction). Tranylcypromine is the same drug class, so it is worth caution. If you take tranylcypromine, discuss ginseng with your prescriber rather than starting it on your own.

PMID 3597812 · PMID 19719333 · BNF: Tranylcypromine

Reviewer-flagged: awaiting clinical-reviewer sign-off.

Additive serotonergic activity

Red 5-HTP

5-HTP raises serotonin levels. Combined with an MAOI like tranylcypromine, this can produce severe serotonin syndrome. Do not combine.

BNF: Tranylcypromine

Tryptophan is the building block your body uses to make serotonin, and tranylcypromine is an MAOI that blocks serotonin breakdown. Combining them can drive serotonin to dangerous levels and has caused toxic reactions in published cases with this drug class. Do not combine.

PMID 3976924 · PMID 2035713 · PMID 15784664 · BNF: Tranylcypromine

Rhodiola appears to slow the same enzyme (monoamine oxidase) that tranylcypromine blocks. Stacking the two could push serotonin and related signals too high, risking serotonin syndrome or a dangerous rise in blood pressure. We treat this as a do-not-combine pair without specialist sign-off.

PMID 19168123 · PMID 25413939 · PMID 30659561 · BNF: Tranylcypromine

Reviewer-flagged: awaiting clinical-reviewer sign-off.

Red SAMe

SAMe raises serotonin-related activity, and tranylcypromine is an MAOI that blocks serotonin breakdown. Stacking the two could push serotonin too high, risking serotonin syndrome. We treat this as a do-not-combine pair without specialist sign-off.

PMID 7854515 · PMID 2035713 · PMID 15784664 · BNF: Tranylcypromine

Reviewer-flagged: awaiting clinical-reviewer sign-off.

Saffron has its own antidepressant effect that appears to act on serotonin, and tranylcypromine is an MAOI that blocks serotonin breakdown. Stacking the two could push serotonin too high, risking serotonin syndrome. We treat this as a do-not-combine pair without specialist sign-off.

PMID 15852492 · PMID 17174460 · PMID 36678554 · BNF: Tranylcypromine

Reviewer-flagged: awaiting clinical-reviewer sign-off.

St John's Wort with an MAOI like tranylcypromine can cause hypertensive crisis and serotonin syndrome. This is a strict do-not-combine.

BNF: Tranylcypromine

What this list does not say. Pairs not flagged here are not implicitly safe. They are either not yet in our database, or fall outside our inclusion scope (food-supplement interactions only; for drug-drug interactions, the BNF is authoritative). Use the checker below to surface any supplement, and submit a missing item if you take something we have not catalogued.

Loading database stats…
For adults over 18. This tool gives evidence-graded information, not medical advice. Always discuss changes with your GP, especially if you take any medication, are pregnant, breastfeeding, or have a serious health condition.
Type the supplement name. Click each match to add it.
Brand or generic name works. Click each match to add it.
Anything we should know? (optional)
Pick any that apply. We adjust the findings where context changes the answer.
Add at least one supplement and one medication to check.
Not sure where to start? Try one:
How we decide

How we grade severity, choose what's in scope, and what we exclude.

Every call on this page is reasoned. We publish the full rubric for severity tiers, the medication inclusion logic, the evidence grades we accept, and what we deliberately leave out. About three thousand words. Worth reading once if you use this tool more than occasionally.

Read the full methodology
Your whole stack

Want this reasoning across everything you take?

This page checks the pairs you enter. A personalised Distil report applies the same graded, cited reasoning to your whole stack: your goals, conditions, medications, diet, and the compounds worth adding or dropping. The interactions check is one section of it. You can read a real one in full before you decide.

See a real sample report
Distil's interactions database is reviewed and updated every quarter. We grade evidence transparently and publish our methodology, including every database change, at /about/methodology. This tool is information, not a substitute for clinical judgement. If you take medication and supplements together, your GP or pharmacist can review your full regimen against your medical history. If you want a full personalised stack reasoned against this same database, the Distil report is the next step up.